Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation
Public ClinicalTrials.gov record NCT01058434. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multi-center, Non-randomized, Open-label Study of TKI258 in Patients With Relapsed or Refractory Multiple Myeloma, Who Are With or Without t(4;14) Translocation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate safety and efficacy of TKI258 in patients with relapsed or refractory multiple myeloma
Study identification
- NCT ID
- NCT01058434
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 43 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2010 (Type not available)
- Primary completion
- Feb 2013 (Actual)
- Completion
- Feb 2013 (Actual)
- Last update posted
- Dec 19, 2020
2010 – 2013
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama / Mitchell Cancer Institute Dept. of Mitchell Cancer Inst. | Mobile | Alabama | 36688 | — |
| Central Hematology Oncology Medical Group | Alhambra | California | 91801 | — |
| Central Coast Medical Oncology Corporation | Santa Maria | California | 93454 | — |
| St. Jude Heritage Medical Group Virginia Crosson Cancer Center | Yorba Linda | California | 92886 | — |
| Kootenai Medical Center Kootenai Medical Center | Coeur d'Alene | Idaho | 83814 | — |
| Hematology and Oncology Specialists Dept of Hem&Onc Specialist - 2 | Metairie | Louisiana | 70006 | — |
| Mayo Clinic - Rochester Rochester | Rochester | Minnesota | 55905 | — |
| Memorial Sloan Kettering Cancer Center MSKCC | New York | New York | 10021 | — |
| Duke University Medical Center Dept. of DUMC (4) | Durham | North Carolina | 27710 | — |
| Lancaster Cancer Center | Lancaster | Pennsylvania | 17601 | — |
| Cancer Centers of the Carolinas Dept. of CC of the Carolinas | Greenville | South Carolina | 29605 | — |
| University of Tennessee Cancer Institute SC-2 | Memphis | Tennessee | 38104 | — |
| University of Texas Southwestern Medical Center UTSW Medical Center | Dallas | Texas | 75390-8527 | — |
| University of Wisconsin SC | Madison | Wisconsin | 53792 | — |
| Medical College of Wisconsin Med College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01058434, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 19, 2020 · Synced Nov 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01058434 live on ClinicalTrials.gov.